Shay Shemesh
Vermögen: 33 Mio $ am 30.06.2026
Vermögen: 33 Mio $ am 30.06.2026
Shay Shemesh is the founder of Nuvectis Pharma, Inc., founded in 2020, holding the title of EVP, Chief Development & Operations Officer.
Former jobs include Head-Clinical Operations at Keryx Biopharmaceuticals, Inc. and Senior VP-Clinical & Regulatory Affairs at Stemline Therapeutics, Inc. from 2015 to 2020.
Education includes undergraduate and graduate degrees from Bar-Ilan University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NUVECTIS PHARMA, INC. 6,76 % | 13.04.2026 | 1.793.068 ( 6,76 % ) | 33 Mio $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| NUVECTIS PHARMA, INC. | Gründer | 27.07.2020 |
| Unternehmen | Position | Ende |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 |
| KERYX BIOPHARMACEUTICALS | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Stemline Therapeutics, Inc.
Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
Bar-Ilan University
Bar-Ilan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen